StemoniX, acquired by AxoSim
Biotechnology-Research
Website
Company Tagline
Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research
Industry Category
Business Keywords
Company Description
StemoniX, acquired by AxoSim, is a leading biotechnology research company specializing in innovative solutions for toxicology and drug discovery research. Located in Maple Grove, Minnesota, at 13300 67th Ave N, StemoniX offers pre-plated, human iPSC-derived microOrgans that serve as a physiologically relevant screening platform for CNS drug discovery and toxicity testing.
The microBrain™ technology from StemoniX replicates vital aspects of human CNS biology, featuring cortical neurons and astrocytes that self-organize and establish functional 3D networks. These microBrain™ organoids are known for their remarkably consistent performance, making them an ideal choice for high-throughput neurotoxicology, neuromodulation, and drug discovery investigations. StemoniX is committed to advancing the field of biotechnology through cutting-edge research and development.
With a focus on providing advanced tools and technologies, StemoniX continues to support researchers and scientists in their quest to develop new and effective treatments. StemoniX invites you to explore the possibilities of its microBrain™ technology and discover how it can enhance your research outcomes. We invite the manager of StemoniX to create a customized and exclusive company showcase and product listing on our platform.
Key Personnel / Employees
Compare Companies Side by Side
Compare StemoniX, acquired by AxoSim with 3 companies in Biotechnology-Research
| Comparison Field |
StemoniX, acquired by Axo...Main Company |
Drug Target ReviewView Profile |
Ananda DevicesView Profile |
Molecular DevicesView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 2015 | 1983 |
|
Company Size
|
— | 51-200 | 11-50 | 1,001-5,000 |
|
City
|
Maple Grove, Minnesota | Brasted, Kent | Laval, QC | San Jose, CA |
|
Country
|
United States | United Kingdom | Canada | United States |
|
Skills & Keywords
Comparing with main company
|
17 Total Skills
Biotechnology Research
Drug Discovery
Toxicology
iPSC-derived microOrgans
CNS drug discovery
Neurotoxicology
Neuromodulation
Human iPS Cells
Stem Cells
Cardiomyocytes
in vitro Assay Development
iPS Cell Manufacturing
Disease Modeling
Hazard Identification
Astrocytes
Neurons
High Throughput Screening
|
18 Total
18 Unique
Unique Skills:
Antibodies
Assays
Biomarkers
Drug Targets
Enzymes
Flow Cytometry
+12
|
25 Total
25 Unique
Unique Skills:
ALS
Alzheimer's
Anti-Toxin
Biomarker Identification
Biotechnology
Cell Culture
+19
|
9 Total
9 Unique
Unique Skills:
Antibody or Protein Development
Cell Line
Clone Selection
Colony Pickers
Conventional & Automated Electrophysiology
Data Acquisition & Analysis Software
+3
|
4
Total Companies1983
Oldest Founded3
Countries68
Unique SkillsSimilar Companies
Other organizations in the same industry
aMBR genomics
Biotechnology-ResearchReimagining Cancer Detection with the Power of Midbody Remnants
Coswald Pharmaceutical/Biotechnology Consulting LL...
Biotechnology-ResearchBiopharmaceutical Production and Quality Professional - Specializing in Oligonucleotide MFG, Develop...
Alternative Company Names
This company is also known as